Annual Report 2015

Vitrolife has today published its Annual Report for 2015. The document is
attached to this press release and is also available on
www.vitrolife.com (http://www.vitrolife.com/en/Corporate/).
Distribution of the printed versions of the annual reports to those shareholders
who have requested dispatch, will be done by mail during the week commencing 11
April.
The printed version of the Annual Report can be ordered on the company's website
www.vitrolife.com (http://www.vitrolife.com/en/Corporate/), by phone +46 (0)31
721 80 00 or by email info@vitrolife.com.
Gothenburg, Sweden

April 1, 2016

VITROLIFE AB (publ)
Queries should be addressed to:
Mikael Engblom, CFO, tel 46 31 721 80 14

Vitrolife is required to publish the information in this press release in
accordance with the Swedish Securities Market Act and/or the Financial
Instruments Trading Act. The information was submitted for publication on April
1, 2016 at 08:30 a.m.

This is a translation of the Swedish version of the press release. When in
doubt, the Swedish wording prevails.
________________________________________________________________________________
_ 
________________________________

Vitrolife is an international medical device Group. Vitrolife develops, produces
and markets medical devices for assisted reproduction. Work is also carried out
to enable the use and handling of stem cells for therapeutic purposes

Vitrolife has approximately 330 employees and the company's products are sold
in about 110 markets. The company is headquartered in Gothenburg, Sweden, and
there are also offices in USA, Australia, France, Italy, United Kingdom, China,
Japan, Hungary and Denmark. The Vitrolife share is listed on NASDAQ OMX
Stockholm, Mid Cap.

Vitrolife AB (publ), Box 9080, SE-400 92 Göteborg, Sweden. Corporate identity
number 556354-3452. Tel: 46 31 721 80 00. Fax: 46 31 721 80 99. E-mail:
info@vitrolife.com. Website: www.vitrolife.com/